These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 4787947

  • 1. [Compounds stimulating central catecholamine receptors].
    Grabowska M.
    Postepy Hig Med Dosw; 1973; 27(2):209-39. PubMed ID: 4787947
    [No Abstract] [Full Text] [Related]

  • 2. On the functional role of pre- and postsynaptic catecholamine receptors in brain.
    Strömbom U.
    Acta Physiol Scand Suppl; 1975; 431():1-43. PubMed ID: 181950
    [No Abstract] [Full Text] [Related]

  • 3. Influence of chemical stimulation of central dopaminergic system on the open field behaviour of rats.
    Kulkarni SK, Dandiya PC.
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):45-50. PubMed ID: 1233511
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The actions of amphetamine on neurotransmitters: a brief review.
    Moore KE.
    Biol Psychiatry; 1977 Jun; 12(3):451-62. PubMed ID: 17437
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An investigation on the behavioral and hypothermic effects of yohimbine: interaction with drugs affecting central and peripheral monoamines.
    Papeschi R.
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):61-80. PubMed ID: 4276928
    [No Abstract] [Full Text] [Related]

  • 11. A comparison between a melanocyte-stimulating hormone inhibitory factor (MIF-I) and substances known to activate central dopamine receptors.
    Cox B, Kastin AJ, Schnieden H.
    Eur J Pharmacol; 1976 Mar; 36(1):141-7. PubMed ID: 4332
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A neuropharmacological analysis of central nervous system catecholamine systems in development protein malnutrition.
    Leahy JP, Stern WC, Resnick O, Morgane PJ.
    Dev Psychobiol; 1978 Jul; 11(4):361-70. PubMed ID: 566687
    [Abstract] [Full Text] [Related]

  • 15. Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography.
    Miller R, Horn A, Iversen L, Pinder R.
    Nature; 1974 Jul 19; 250(463):238-41. PubMed ID: 4368645
    [No Abstract] [Full Text] [Related]

  • 16. Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems.
    Randrup A, Mogilnicka E.
    Pol J Pharmacol Pharm; 1976 Jul 19; 28(6):551-6. PubMed ID: 1034919
    [Abstract] [Full Text] [Related]

  • 17. The role of biogenic amines in the extra-pyramidal system.
    Ernst AM.
    Acta Physiol Pharmacol Neerl; 1969 Jun 19; 15(2):141-54. PubMed ID: 5799067
    [No Abstract] [Full Text] [Related]

  • 18. Role of 5-HT in the action of some drugs affecting extrapyramidal system.
    Gumulka W, Kostowski W, Czlonkowski A.
    Pharmacology; 1973 Jun 19; 10(6):363-72. PubMed ID: 4274062
    [No Abstract] [Full Text] [Related]

  • 19. Psychotropic actions of clonidine.
    Lal H, Shearman GT.
    Prog Clin Biol Res; 1981 Jun 19; 71():99-145. PubMed ID: 6276904
    [No Abstract] [Full Text] [Related]

  • 20. The influence of insulin hypoglycemia on central dopaminergic structures of the rat.
    Kleinrok Z, Ossowska G, Stelmasiak M, Juszkiewicz M.
    Pol J Pharmacol Pharm; 1983 Jun 19; 35(6):489-95. PubMed ID: 6377282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.